Socioeconomic determinants of global distribution of multiple sclerosis: an ecological investigation based on Global Burden of Disease data

被引：0
作者：
Vahid Kazemi Moghaddam
Aisha S. Dickerson
Edris Bazrafshan
Seyedeh Nahid Seyedhasani
Fereshteh Najafi
Mostafa Hadei
Jalil Momeni
Ghasem Moradi
Mohammad Sarmadi
机构：
[1] Neyshabur University of Medical Sciences,Department of Environmental Health Engineering
[2] Department of Epidemiology,Department of Environmental Health Engineering, School of Health
[3] Johns Hopkins Bloomberg School of Public Health,Health Sciences Research Center
[4] Torbat Heydariyeh University of Medical Sciences,Department of Health Information Technology, School of Paramedical Sciences
[5] Torbat Heydariyeh University of Medical Sciences,Department of Epidemiology and Biostatistics, School of Public Health
[6] Torbat Heydariyeh University of Medical Sciences,Department of Environmental Health Engineering, School of Public Health
[7] Tehran University of Medical Sciences,Student Research Committee
[8] Tehran University of Medical Science,Neuroscience Research Center
[9] Torbat Heydariyeh University of Medical Sciences,undefined
[10] Torbat Heydariyeh University of Medical Sciences,undefined
来源：
BMC Neurology | / 21卷
关键词：
Multiple sclerosis; Human development index; Prosperity index; Socioeconomic factors; Ecology study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Prognostic indicators for hospitalization and ICU admission in people with multiple sclerosis and COVID-19: an analysis of the COVID-19 in MS global data sharing initiative dataset
    Garcia-Dominguez, Maria A.
    Kipkorir, Vincent
    Srichawla, Bahadar S.
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (02): : 720 - 725
  • [42] CEST MRI with distribution-based analysis for assessment of early stage disease activity in a mouse model of multiple sclerosis: An initial study
    Liu, Tao
    Chen, Yanrong
    Thomas, Aline M.
    Song, Xiaolei
    NMR IN BIOMEDICINE, 2019, 32 (11)
  • [43] User Experience of a Large-Scale Smartphone-Based Observational Study in Multiple Sclerosis:Global, Open-Access, Digital-Only Study
    Galati, Adriano
    Kriara, Lito
    Lindemann, Michael
    Lehner, Rea
    Jones, J. B.
    JMIR HUMAN FACTORS, 2024, 11
  • [44] Early predictors of injectable disease modifying drugs suboptimal response based on clinical and radiological data assessment in Polish Multiple Sclerosis patients
    Wawrzyniak, Slawomir
    Koziarska, Dorota
    Kulakowska, Alma
    Bartosik-Psujek, Halina
    Adamczyk-Sowa, Monika
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2019, 53 (02) : 131 - 137
  • [45] Gender difference of geographic distribution of the stroke incidence affected by socioeconomic, clinical and urban-rural factors: an ecological study based on data from the Brest stroke registry in France
    Padilla, Cindy M.
    Foucault, Anais
    Grimaud, Olivier
    Nowak, Emmanuel
    Timsit, Serge
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [46] Gender difference of geographic distribution of the stroke incidence affected by socioeconomic, clinical and urban-rural factors: an ecological study based on data from the Brest stroke registry in France
    Cindy M. Padilla
    Anais Foucault
    Olivier Grimaud
    Emmanuel Nowak
    Serge Timsit
    BMC Public Health, 21
  • [47] Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium
    Jakimovski, Dejan
    Kavak, Katelyn S.
    Coyle, Patricia K.
    Goodman, Andrew D.
    Gottesman, Malcolm
    Zivadinov, Robert
    Weinstock-Guttman, Bianca
    JOURNAL OF NEUROLOGY, 2024, 271 (02) : 711 - 722
  • [48] Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium
    Dejan Jakimovski
    Katelyn S. Kavak
    Patricia K. Coyle
    Andrew D. Goodman
    Malcolm Gottesman
    Robert Zivadinov
    Bianca Weinstock-Guttman
    Journal of Neurology, 2024, 271 : 711 - 722
  • [49] Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in adolescents and young adults (15-39 years): an analysis based on the global burden of disease study 2021
    Zhao, Meng
    Zhai, Hongrui
    Li, Han
    Wei, Feiran
    Ma, Hongfei
    Liu, Yangyang
    Li, Wei
    Wei, Pingmin
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [50] Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data
    Simbrich, Alexandra
    Thibaut, Jasmine
    Khil, Laura
    Berger, Klaus
    Riedel, Oliver
    Schmedt, Niklas
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1439 - 1457
12345